Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Acquires Sample Prep/LC Company Cohesive Technologies

NEW YORK (GenomeWeb News) — Thermo Fisher Scientific today said it has acquired sample-extraction and liquid-chromatography company Cohesive Technologies for an undisclosed sum.
 
The deal, announced a little more than a month after Thermo sealed its merger with Fisher Scientific, aims to expand Thermo’s services by coupling Cohesive’s sample prep with its mass spec to “create end-to-end workflow solutions for drug and other organic molecule analyses.”
 
The company said this will both improve its sample throughput and raise the detection limits for its LC/MS analysis business.
 
Cohesive Technologies has yearly revenues of roughly $15 million, Thermo said.
 
Financial terms of the deal were not released.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.